MedPath

The effect of Agomalatin on resistant obsessive compulsive disorder patients

Phase 2
Recruiting
Conditions
obsessive-compulsive disorder (OCD).
Obsessive-compulsive disorder
Registration Number
IRCT20190726044339N3
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with resistant obsessive-compulsive disorder who have not taken any medication for 3 months before the start of the study
Score of the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) above 15

Exclusion Criteria

Having other psychiatric disorder
Pregnancy and lactation
Having Hepatic disorder
Receive concomitant psychotherapy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Obsession severity. Timepoint: At the beginning of the study and at the 12th week. Method of measurement: Yale-Brown Obsessive Compulsive Scale (Y-BOCS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath